Natco Pharma Limited
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas.NATCO has established its presence in all three business segments viz. finished dosage formulations (“FDF”), active pharmaceutical ingredients (“APIs”), Contract Manufacturing Business.
What Natco files
- Others62
- Investor Meet41
- Updates27
- Dividend/Bonus10
- Board Meeting9
- PPTs7
NATCO Pharma posted robust financials: revenue grew 16% to ₹4,784 Cr, PAT jumped 36% to ₹1,883 Cr, with 53.30% EBITDA. The company expanded global presence and R&D (₹373.3 Cr spend) in new therapies. NATCO earned a GreenCo Gold rating, upholding strong compliance with no product recalls.
Natco Pharma has announced a board meeting to review the financial results for the quarter and half-year. The U.S. FDA recently concluded an inspection at its Kothur facility, resulting in 7 observations in Form-483. The company is confident about resolving these issues within the given timeline and remains committed to...
Natco Pharma has announced a board meeting to discuss the recent U.S. FDA inspection of its Mekaguda API plant. The FDA noted one procedural observation, which Natco expects to resolve fully. The company reaffirms its commitment to cGMP standards and maintaining global product quality. No financial impact reported.
NATCO Pharma Limited reported consolidated total revenue of ₹651.1 Crore for the third quarter of FY2025, a decline from ₹795.6 Crore in the same quarter last year. The net profit for the period was ₹132.4 Crore, compared to ₹212.7 Crore in the previous year, indicating the impact of reduced contribution...
### Company Update - Sustainability Report 2023-24 NATCO Pharma has released its Sustainability Report for 2023-24, reaffirming its commitment to sustainable practices across its operations. The company is focusing on reducing its carbon footprint, with 15% of its energy sourced from renewables, targeting 35% by 2035 and aiming for carbon...